Industry news

Home > News > Content
Pharmaceutical Intermediates Will Welcome Good Development Opportunities
Sep 01, 2017

According to the prospective industry Research Institute released the "China pharmaceutical intermediates industry market research and investment analysis report" is expected, with the drug patent expiration, the next five to ten years, with the price advantage of generics will usher in the explosive growth of production and sales are expected to soar. The outbreak of generic drugs will bring a wider market space and good development opportunities for pharmaceutical intermediates, and the future prospect can be expected.

Pharmaceutical intermediates refer to some chemical raw materials or chemical products used in the process of drug synthesis. They are also an important part of fine chemicals, and have become the core of developing chemical industry in every country. In recent years, China has made great progress in fine chemicals, and the rate of refinement has been continuously improved. It has created a good atmosphere for the development of pharmaceutical intermediates.

Because of its high investment efficiency, high profit rate and high added value, medical intermediates have attracted much attention and favor from all walks of life. The Chinese government also attaches great importance to the development of pharmaceutical intermediates, and has issued a series of encouraging policies and measures.

Under the impetus of the government, China's pharmaceutical intermediates industry developed rapidly. At present, it has basically met the chemical raw materials and intermediates required for pharmaceutical production, and has shown the following six characteristics.

On the one hand, pharmaceutical intermediates for many enterprises and private enterprises, the investment scale is generally small, the amount of investment in the millions to 889, but the operation is more flexible, able to quickly and efficiently respond to changes in the market;

Secondly, the distribution of pharmaceutical intermediates is more concentrated, mainly in Jiangsu and Zhejiang provinces, especially in Zhejiang, Taizhou, Jiangsu and Jintan provinces, where a large number of pharmaceutical intermediates have been collected;

Third, the pharmaceutical intermediates enterprises are facing increasing pressure on environmental protection, and it is imperative to build environmental protection treatment facilities;

Fourth, the product updates quickly, new varieties emerge in an endless stream, forcing pharmaceutical intermediates to follow up or improve the process;

Fifth, pharmaceutical intermediates industry competition and disorderly, small and medium sized enterprises more and more being joined, is not conducive to the development of pharmaceutical intermediates industry cluster;

Six, the pharmaceutical intermediates enterprises generally lack of innovation, there are low-level duplication phenomenon, in the world with independent intellectual property rights of intermediates, medicines are numbered.

From the above development characteristics, China's pharmaceutical intermediates and international advanced level is still far from each other. In the future to promote the development of pharmaceutical intermediates industry, should pay attention to scientific research, interdisciplinary, comprehensive, high starting point for establishing the standard engineering center, providing a platform for new birth, at the same time to carry out prediction and evaluation work, to achieve rapid and healthy development of pharmaceutical intermediates.





Copyright © Shandong Yangcheng Biotech Co.,Ltd All Rights Reserved.Tel: +86-537-2318768